UBS O'Connor’s Carney Technology Acquisition Corp. II Class A Common Stock CTAQ Stock Holding History

UBS O'Connor’s Portfolio CTAQ Stock Details CTAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-386,583	Closed	-$3.96M	–	850
2022 Q4	$3.96M	Sell	386,583 -3,799	-1%	-$38.2K	0.07%	246
2022 Q3	$3.88M	Sell	390,382 -39,246	-9%	-$389K	0.04%	359
2022 Q2	$4.24M	Hold	429,628	–	–	0.04%	363
2022 Q1	$4.22M	Buy	429,628 +7,601	+2%	+$74.4K	0.05%	326
2021 Q4	$4.12M	Buy	422,027 +11,320	+3%	+$111K	0.04%	336
2021 Q3	$4.01M	Hold	410,707	–	–	0.03%	351
2021 Q2	$3.98M	Hold	410,707	–	–	0.04%	319
2021 Q1	$3.98M	Buy	+410,707	New	+$4.14M	0.06%	314

UBS O'Connor's CTAQ Position: Q1 2023 in Review

UBS O'Connor sold out of Carney Technology Acquisition Corp. II Class A Common Stock (CTAQ) in Q1 2023, closing a stake of 386,583 shares — an estimated $3.96M sold.

UBS O'Connor first reported a position in CTAQ in Q1 2021 and held it in 8 quarters. The position peaked at $4.24M in Q2 2022. 0 funds tracked by Wall St. Rank hold CTAQ as of Q1 2023.

UBS O'Connor reported no remaining Carney Technology Acquisition Corp. II Class A Common Stock position as of Q1 2023 after selling out during the quarter.
UBS O'Connor sold 386,583 Carney Technology Acquisition Corp. II Class A Common Stock shares in Q1 2023, an estimated $3.96M.
UBS O'Connor first reported a position in Carney Technology Acquisition Corp. II Class A Common Stock in Q1 2021 and held it in 8 quarters.
UBS O'Connor's Carney Technology Acquisition Corp. II Class A Common Stock position peaked at $4.24M in Q2 2022.
0 funds tracked by Wall St. Rank held Carney Technology Acquisition Corp. II Class A Common Stock as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.